Exhibit 32.1
AMPIO PHARMACEUTICALS, INC.
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing of the quarterly report on Form 10-Q/A for the quarter ended September 30, 2019 (the “Report”) by Ampio Pharmaceuticals, Inc. (the “Company”), each of the undersigned hereby certifies that, to his knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
Dated: January 14, 2020 | /s/ Michael Macaluso |
| Michael Macaluso |
| Chairman and Chief Executive Officer |
|
|
Dated: January 14, 2020 | /s/ Daniel G. Stokely |
| Daniel G. Stokely |
| Chief Financial Officer and Secretary |
